Tvardi Therapeutics (TVRD) Institutional Ownership $29.92 -0.35 (-1.16%) As of 08/29/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tvardi Therapeutics (NASDAQ:TVRD)CurrentInstitutional OwnershipPercentage44.66%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$24.39MNumber ofInstitutional Sellers(last 12 months)0 Get TVRD Insider Trade Alerts Want to know when executives and insiders are buying or selling Tvardi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TVRD Institutional Buying and Selling by Quarter Tvardi Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/16/2025 Headlands Technologies LLC3,431$80K0.0%N/A0.037% 8/15/2025 Bank of America Corp DE17,085$399K0.0%N/A0.183% 8/15/2025 683 Capital Management LLC176,030$4.11M0.3%N/A1.881% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.1,863$43K0.0%N/A0.020% 8/14/2025 Slate Path Capital LP704,118$16.43M0.3%N/A7.523% 8/13/2025 Marshall Wace LLP24,980$583K0.0%N/A0.267% 8/13/2025 New York State Common Retirement Fund4,000$92K0.0%N/A0.043% 8/12/2025 JPMorgan Chase & Co.1,668$39K0.0%N/A0.018% 8/8/2025 Geode Capital Management LLC112,138$2.62M0.0%N/A1.198% (Data available from 1/1/2016 forward) TVRD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TVRD shares? During the previous two years, 9 institutional investors and hedge funds held shares of Tvardi Therapeutics. The most heavily invested institutionals were Slate Path Capital LP ($16.43M), 683 Capital Management LLC ($4.11M), Geode Capital Management LLC ($2.62M), Marshall Wace LLP ($583K), Bank of America Corp DE ($399K), New York State Common Retirement Fund ($92K), and Headlands Technologies LLC ($80K).Learn more on Tvardi Therapeutics' institutional investors. What percentage of Tvardi Therapeutics' stock is owned by institutional investors? 44.66% of Tvardi Therapeutics' stock is owned by institutional investors. Learn more on TVRD's institutional investor holdings. Which institutional investors have been buying Tvardi Therapeutics' stock? Of the 9 institutional investors that purchased Tvardi Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Slate Path Capital LP ($704.12K), 683 Capital Management LLC ($176.03K), Geode Capital Management LLC ($112.14K), Marshall Wace LLP ($24.98K), Bank of America Corp DE ($17.09K), New York State Common Retirement Fund ($4K), and Headlands Technologies LLC ($3.43K). How much institutional buying is happening at Tvardi Therapeutics? Institutional investors have bought a total of 1,045,313 shares in the last 24 months. This purchase volume represents approximately $24.39M in transactions. Related Companies Nuvation Bio Major Shareholders Verve Therapeutics Major Shareholders Valneva Major Shareholders Cronos Group Major Shareholders Praxis Precision Medicines Major Shareholders Mineralys Therapeutics Major Shareholders Upstream Bio Major Shareholders Oric Pharmaceuticals Major Shareholders atai Life Sciences Major Shareholders Pharming Group Major Shareholders This page (NASDAQ:TVRD) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tvardi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tvardi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TVRD Stock Alerts